The management of a patient with an operable carcinoma of the oesophagus.
作者信息
Crosby Tom, Evans Mererid, Gillies Richard S, Maynard Nicholas D
机构信息
Department of Clinical Oncology, Velindre Cancer Centre, Cardiff, UK.
出版信息
Ann R Coll Surg Engl. 2009 Jul;91(5):366-70. doi: 10.1308/003588409X432428.
Abstract
摘要
相似文献
1
The management of a patient with an operable carcinoma of the oesophagus.可手术食管癌患者的管理
Ann R Coll Surg Engl. 2009 Jul;91(5):366-70. doi: 10.1308/003588409X432428.
2
Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy.分析因食管癌而接受新辅助治疗后择期手术但最终未行食管癌切除术的患者。
World J Surg Oncol. 2019 May 27;17(1):89. doi: 10.1186/s12957-019-1630-8.
3
Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?谁能从局部晚期食管癌的新辅助放化疗中获益？
J Gastroenterol Hepatol. 2009 May;24(5):708-10. doi: 10.1111/j.1440-1746.2009.05838.x.
4
Therapy for esophageal cancer.
Cancer Treat Res. 2001;105:387-98. doi: 10.1007/978-1-4615-1589-0_15.
5
Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy.定义食管癌的治愈：食管癌切除术后 5 年实际幸存者的分析。
Ann Surg Oncol. 2011 Jun;18(6):1766-74. doi: 10.1245/s10434-010-1508-z. Epub 2011 Jan 7.
6
Carcinoma of the esophagus.食管癌
Ann Surg. 1970 May;171(5):746-51. doi: 10.1097/00000658-197005000-00014.
7
Endosonographic assessment of multimodality therapy predicts survival of oesophageal carcinoma patients.多模态治疗的内镜超声评估可预测食管癌患者的生存率。
Gastrointest Endosc. 2001 Jul;54(1):132-4.
8
Neoadjuvant treatment of oesophageal adenocarcinoma.食管腺癌的新辅助治疗
Minerva Chir. 2004 Oct;59(5):461-70.
9
Improved long-term survival after esophagectomy for esophageal cancer: influence of epidemiologic shift and neoadjuvant therapy.食管癌切除术的长期生存改善：流行病学变化和新辅助治疗的影响。
J Gastrointest Surg. 2013 Jul;17(7):1193-201. doi: 10.1007/s11605-013-2212-7. Epub 2013 May 2.
10
[Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].[可手术切除的非转移性食管癌患者的治疗决策]
Zentralbl Chir. 2014 Feb;139(1):32-6. doi: 10.1055/s-0033-1360295. Epub 2014 Feb 28.
引用本文的文献
1
Efficacy and safety of cisplatin + docetaxel + 5-FU + leucovorin + methotrexate and epirubicin combination chemotherapy for advanced esophageal cancer.顺铂+多西他赛+5-氟尿嘧啶+亚叶酸钙+甲氨蝶呤与表柔比星联合化疗治疗晚期食管癌的疗效与安全性
PLoS One. 2025 Jun 26;20(6):e0326056. doi: 10.1371/journal.pone.0326056. eCollection 2025.
2
Postoperative Radiotherapy in Curatively Resected Esophageal Squamous Cell Carcinoma With Occult Recurrent Laryngeal Nerve Lymph Node Metastasis.根治性切除术后隐匿性喉返神经淋巴结转移的食管鳞癌术后放疗。
Cancer Control. 2024 Jan-Dec;31:10732748241285142. doi: 10.1177/10732748241285142.
3
Efficacy and safety of irinotecan combined with raltitrexed or irinotecan monotherapy for salvage chemotherapy of esophageal squamous cell cancer: A prospective, open label, randomized phase II study.伊立替康联合雷替曲塞或伊立替康单药治疗食管鳞癌挽救化疗的疗效和安全性：一项前瞻性、开放标签、随机Ⅱ期研究。
Cancer Med. 2023 Aug;12(15):16108-16118. doi: 10.1002/cam4.6264. Epub 2023 Jun 16.
4
Endoscopic Submucosal Dissection Followed by Concurrent Chemoradiotherapy in Patients with Early Esophageal Cancer with a High Risk of Lymph Node Metastasis.早期食管癌伴淋巴结转移高危患者内镜下黏膜下剥离术联合同步放化疗
Clin Endosc. 2019 Sep;52(5):502-505. doi: 10.5946/ce.2018.176. Epub 2019 May 14.
5
The expression of and its inhibitory effect on cell biological behavior in esophageal squamous cell carcinoma.其在食管鳞状细胞癌中的表达及其对细胞生物学行为的抑制作用。
Onco Targets Ther. 2017 Feb 27;10:1217-1226. doi: 10.2147/OTT.S125742. eCollection 2017.
6
Postoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a review.pT2-3N0M0期食管癌的术后放射治疗——综述
Tumour Biol. 2016 Nov;37(11):14443-14450. doi: 10.1007/s13277-016-5373-7. Epub 2016 Sep 18.
7
Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.DNA修复基因的遗传变异可预测接受铂类辅助化疗的食管鳞状细胞癌患者的生存情况。
J Transl Med. 2016 May 31;14(1):154. doi: 10.1186/s12967-016-0903-z.
8
Lymphatic spreading and lymphadenectomy for esophageal carcinoma.食管癌的淋巴转移与淋巴结清扫术
World J Gastrointest Surg. 2016 Jan 27;8(1):90-4. doi: 10.4240/wjgs.v8.i1.90.
9
The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma.辅助放疗对根治性切除的T3期食管鳞状细胞癌的影响。
J Cancer Res Clin Oncol. 2016 Jan;142(1):277-86. doi: 10.1007/s00432-015-2041-z. Epub 2015 Sep 2.
10
Activating transcription factor 4 promotes esophageal squamous cell carcinoma invasion and metastasis in mice and is associated with poor prognosis in human patients.激活转录因子4促进小鼠食管鳞状细胞癌的侵袭和转移，并与人类患者的不良预后相关。
PLoS One. 2014 Jul 31;9(7):e103882. doi: 10.1371/journal.pone.0103882. eCollection 2014.
本文引用的文献
1
Oxford experience with neoadjuvant chemotherapy and surgical resection for esophageal adenocarcinomas and squamous cell tumors.牛津大学关于食管腺癌和鳞状细胞肿瘤新辅助化疗及手术切除的经验。
Dis Esophagus. 2008;21(3):201-6. doi: 10.1111/j.1442-2050.2007.00752.x.
2
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.与有限经裂孔切除术相比，扩大经胸段切除术治疗中/远端食管癌的随机临床试验五年生存率
Ann Surg. 2007 Dec;246(6):992-1000; discussion 1000-1. doi: 10.1097/SLA.0b013e31815c4037.
3
Chemoradiation in the management of esophageal cancer.食管癌治疗中的放化疗
J Clin Oncol. 2007 Sep 10;25(26):4110-7. doi: 10.1200/JCO.2007.12.0881.
4
Quality of life during potentially curative treatment for locally advanced oesophageal cancer.局部晚期食管癌潜在治愈性治疗期间的生活质量
Br J Surg. 2007 Nov;94(11):1369-76. doi: 10.1002/bjs.5888.
5
Health-related quality of life among patients cured by surgery for esophageal cancer.接受食管癌手术治愈患者的健康相关生活质量。
Cancer. 2007 Aug 1;110(3):686-93. doi: 10.1002/cncr.22833.
6
[Randomized clinical study of surgery versus radiotherapy alone in the treatment of resectable esophageal cancer in the chest].手术与单纯放疗治疗可切除胸段食管癌的随机临床研究
Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):784-7.
7
A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer.一项在随机多中心III期试验（FFCD 9102）中使用斯皮策生活质量指数的比较性纵向生活质量研究：局部晚期可切除胸段食管鳞癌患者中，放化疗后手术与单纯放化疗的对比。
Ann Oncol. 2006 May;17(5):827-34. doi: 10.1093/annonc/mdl033. Epub 2006 Mar 8.
8
Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE).多中心前瞻性随机试验：比较标准食管癌切除术与放化疗治疗食管鳞状细胞癌的疗效——中国大学食管癌研究组（CURE）的早期结果
J Gastrointest Surg. 2005 Jul-Aug;9(6):794-802. doi: 10.1016/j.gassur.2005.05.005.
9
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.局部晚期食管鳞状细胞癌患者接受放化疗联合或不联合手术治疗的情况。
J Clin Oncol. 2005 Apr 1;23(10):2310-7. doi: 10.1200/JCO.2005.00.034.
10
Postoperative mortality following oesophagectomy and problems in reporting its rate.食管切除术后的死亡率及其报告率方面的问题。
Br J Surg. 2004 Aug;91(8):943-7. doi: 10.1002/bjs.4596.
Zotero 插件